6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
1m ago	CrowdStrike Expands Project QuiltWorks, the Cybersecurity Coalition for Securing Frontier AI Risk
1m ago	Clearmind Medicine Announces Filing of European Patent Application for Novel Psychedelic Compounds for the Treatment of PTSD
2m ago	Every Colgate Smile Has A Story: Celebrating Real People, Real Stories, and Real Impact
2m ago	Clene Announces $7 Million Underwritten Offering of Common Stock
2m ago	Lumen Technologies, Inc. and Qwest Corporation Announce Extension of Early Participation Date and Withdrawal Deadline of Previously Announced Exchange Offers

About

Starpharma Holdings Limited — investor relations, events, news, and company updates on 6ix.

Latest News

FDA confirms path to DEP HER2 first-in-human study

Half Yearly Report and Accounts

Quarterly Activities/Appendix 4C Cash Flow Report

AGM Chair address and CEO presentation

Upfront payment of USD $5.5 million received from Genentech

How Starpharma Holdings Limited runs its investor program on 6ix — audience, formats, and program overview.

Recent Videos

Starpharma (ASX: SPL, US OTC: SPHRY): Delivers strong quarterly result

Starpharma (ASX: SPL, US OTC: SPHRY): Delivers strong quarterly result

Apr 29, 2026

Presentation: Starpharma - Ignite Investment Summit, Hong Kong, April 2026

Presentation: Starpharma - Ignite Investment Summit, Hong Kong, April 2026

Apr 28, 2026

Starpharma (ASX:SPL) CEO Cheryl Maley on developments and workstreams

Starpharma (ASX:SPL) CEO Cheryl Maley on developments and workstreams

Apr 27, 2026

Starpharma (ASX:SPL, US OTC:SPHRY:SPL): FDA validates path to DEP® HER2 first-in-human study

Starpharma (ASX:SPL, US OTC:SPHRY:SPL): FDA validates path to DEP® HER2 first-in-human study

Apr 23, 2026

Community Chat

Ask AI